Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

406
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

881
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
881
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

896
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
896
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

226
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
226
Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

179
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
179

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erythrocyte and Platelet Indices at Admission and Discharge Stratify Long-Term Cardiovascular Risk After Invasive Treatment of Myocardial Infarction.

Journal of clinical medicine·2026
Same author

Decreased persistence of maternal antibodies in infants who are HIV-exposed and uninfected.

The Journal of infectious diseases·2026
Same author

Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey.

BMC infectious diseases·2026
Same author

The COVALAC Study: The Impact of COVID-19 Vaccination During Lactation on SARS-CoV-2-Specific Antibodies in Human Milk-A Prospective Cohort Study.

Journal of human lactation : official journal of International Lactation Consultant Association·2026
Same author

Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020 - January 2021, Belgium.

Archives of public health = Archives belges de sante publique·2026
Same author

Low Serum Lysophospholipids Predict Increased In-Hospital Mortality in Patients With Acute Heart Failure.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Jan 15, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.9K

A Practical Framework to Design Immunization Studies Based on the Beta Distribution.

Stefan Embacher1, Andrea Berghold1, Kirsten Maertens2

  • 1Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.

Statistics in Medicine
|October 7, 2025
PubMed
Summary

Designing immunization studies for antibody kinetics is simplified with a new framework. It uses intuitive information to efficiently determine antibody concentration changes over time, improving research resource allocation.

Keywords:
antibody kineticsimmunization studyoptimal sampling schedulestudy design

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.2K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

Related Experiment Videos

Last Updated: Jan 15, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.9K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.2K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

Area of Science:

  • Immunology
  • Biostatistics
  • Experimental Design

Background:

  • Optimally designed experiments enhance research efficiency by reducing time, cost, and observations.
  • Characterizing antibody kinetics (antibody concentration over time) is a key goal in immunization studies.
  • Nonlinear models for antibody kinetics pose challenges for study design and parameter estimation.

Purpose of the Study:

  • To propose a novel framework for designing immunization studies focused on antibody kinetics.
  • To facilitate study design using simple, understandable information intuitive to medical professionals.
  • To determine optimal sampling schedules for characterizing antibody concentration changes over time.

Main Methods:

  • Assumed mean antibody concentration follows a beta density structure until a plateau.
  • Utilized time and height of maximum concentration and plateau to define the antibody kinetics curve.
  • Employed D-optimality for optimal sampling schedule determination and D-efficiency for design comparison.

Main Results:

  • The proposed framework uniquely determines the antibody kinetics curve using intuitive parameters.
  • Robustness analysis across 12 scenarios showed median D-efficiencies exceeding 0.95.
  • Misspecification of plateau height and time to maximum concentration had the most impact on D-efficiency.

Conclusions:

  • The novel framework simplifies immunization study design for antibody kinetics analysis.
  • The framework's reliance on intuitive information from medical professionals is a significant advantage.
  • The study highlights the robustness and efficiency of the proposed design framework.